Mark Rosenblatt
Founder and CEO @ Rationalwave Capital Partners
Mark Rosenblatt is a seed investor at Rationalwave Capital Partners focused on Software and Biometrics. Mark Rosenblatt is the Founder and CEO of Rationalwave Capital Partners. He attended Yale School of Management.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Mark Rosenblatt invests in
Stages Mark Rosenblatt invests in
Countries Mark Rosenblatt invests in
Investment Focus
Industry
- Software 1 (50%)
- Biometrics 1 (50%)
- Health Care 1 (50%)
- Life Science 1 (50%)
- Biotechnology 1 (50%)
Country
- Israel 1 (50%)
- United States 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
|
|
BactoByte aims to empower caregivers with one-hour bacterial diagnostics and antibiotic screening capability to improve outcomes, reduce mis-diagnostics, and lower health care costs.Based on a proprietary novel basic method, BactoByte’s assay delivers precise and cost-effective identification and direct antibiotics susceptibility testing with80-90% improvement of standard turnaround time.Time reduction, sensitivity, and specificity results in decreased mortality rates, fewer hospital days, and avoidance of associated costs of $1K-50K per patient.BactoByte has technology validation and partnerships with leading medical centers. | Seed / Jul 01, 2019 | |
|
|
TypingDNA provides typing biometrics authentication as a service, enabling companies to recognize people by the way they type. The company's authentication technology compares how people type on their keyboards against previous recordings. Works on both mobiles and PCs. Headquartered in New York, United States, with offices in Romania, EU. | $1.5M / Seed / Jan 31, 2019 |
Co-Investors
About Rationalwave Capital Partners
Rationalwave Capital Partners is a venture capital firm investing in technology companies both public and private. The firm is located in New York and founded by Mark Rosenblatt in 2003.
Rationalwave Capital Partners Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Mark Rosenblatt
Founder and CEO
|
|||
4 more contacts available
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Mark Rosenblatt invest in?
Mark Rosenblatt invests primarily in Software, Biometrics and Health Care startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in Israel. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Mark Rosenblatt last invest?
The most recent investment recorded for Mark Rosenblatt closed in Jul 2019. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!